Search Results - "Lawthom, C"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation by Adewusi, J., Burness, C., Ellawela, S., Emsley, H., Hughes, R., Lawthom, C., Maguire, M., McLean, B., Mohanraj, R., Oto, M., Singhal, S., Reuber, M.

    Published in Epilepsy & behavior (01-05-2020)
    “…This multicenter service evaluation explores the efficacy and tolerability of brivaracetam (BRV) in an unselected, consecutive population in ‘real-life’…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Variability of antiepileptic medication taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy by Williams, J, Lawthom, C, Dunstan, F D, Dawson, T P, Kerr, M P, Wilson, J F, Smith, P E M

    “…Background: Variable compliance with antiepileptic drugs (AEDs) is a potentially preventable cause of sudden unexplained death in epilepsy (SUDEP). Hair AED…”
    Get full text
    Journal Article
  5. 5

    The feminisation of British neurology: implications for workforce planning by Carroll, CB, Tengah, DSNA Pengiran, Lawthom, C, Venables, G

    Published in Clinical medicine (London, England) (01-08-2007)
    “…As in other hospital specialties, an increasing proportion of neurology trainees are female. To predict the workforce implications it is necessary to determine…”
    Get full text
    Journal Article
  6. 6

    031 E-learning in epilepsy by Ferris, A E, Lawthom, C

    “…BackgroundNeurology is widely considered one of the most challenging subjects in the undergraduate medical curriculum, so any improvement in training large…”
    Get full text
    Journal Article
  7. 7

    DESIGN OF THE EPOS STUDY: AN OPEN-LABEL, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE ESLICARBAZEPINE ACETATE AS ADJUNCTIVE TREATMENT TO ONE BASELINE ANTIEPILEPTIC DRUG IN ADULTS WITH PARTIAL-ONSET SEIZURES by Holtkamp, M, Lawthom, C, Chouette, I

    “…Purpose Eslicarbazepine acetate (ESL) is a once-daily voltage-gated sodium channel blocker that was approved in Europe in 2009 as adjunctive therapy in adults…”
    Get full text
    Journal Article
  8. 8

    067 Keys and locks by Slade, P M E, Lawthom, C

    “…This case demonstrates two uncommon conditions presenting in a single patient. A 47-year-old male with a history since childhood of generalised tonic clonic…”
    Get full text
    Journal Article
  9. 9

    SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE (ZEBINIX) IN EVERYDAY CLINICAL PRACTICE USING A RETROSPECTIVE MULTICENTRE AUDIT by Keogh, S, McDonald, P, Lawthom, C, Brodie, MJ, McLean, B, Damodaran, D, Morrow, J, Tittensor, P, Bagary, M

    “…PurposeWe report on the safety and efficacy of eslicarbazepine acetate (ESL) in routine clinical practice.MethodRetrospective multicentre audit of outcomes…”
    Get full text
    Journal Article
  10. 10

    Constipation as a presenting symptom by Lawthom, Charlotte, Durdey, Paul, Hughes, Tom

    Published in The Lancet (British edition) (20-09-2003)
    “…We attempted, without success, to alleviate the constipation using stool softeners, biofeedback, and a 5-day course of intravenous methylprednisolone (a…”
    Get full text
    Journal Article
  11. 11